Vaxcyte, Inc.
PCVX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$212,830 | -$166,573 | -$140,718 | -$137,080 |
| Dep. & Amort. | $5,197 | $4,989 | $4,874 | $4,785 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $35,306 | $36,927 | $30,615 | $24,370 |
| Change in WC | $14,198 | $33,691 | -$49,515 | -$2,485 |
| Other Non-Cash | $14,824 | -$30,200 | -$11,530 | -$991 |
| Operating Cash Flow | -$143,305 | -$121,166 | -$166,274 | -$111,401 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$12,046 | $19,516 | -$26,751 | -$30,027 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | -$349,050 | -$314,485 | -$815,215 |
| Inv. Sales/Matur. | $0 | $436,547 | $464,553 | $288,074 |
| Other Inv. Act. | $133,216 | -$29,271 | $0 | $0 |
| Investing Cash Flow | $121,170 | $77,742 | $123,317 | -$557,168 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $3,235 | $0 | $8 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$3,671 | -$717 | $759 | $4,899 |
| Financing Cash Flow | -$3,671 | $2,518 | $759 | $4,907 |
| Forex Effect | $291 | $800 | $1,172 | $1,350 |
| Net Chg. in Cash | -$25,515 | -$40,106 | -$41,026 | -$662,312 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $308,063 | $348,169 | $389,195 | $1,051,507 |
| End Cash | $282,548 | $308,063 | $348,169 | $389,195 |
| Free Cash Flow | -$155,351 | -$101,650 | -$193,025 | -$141,428 |